1. Massad LS, Einstein MH, Huh WK, et al (2013) 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. Obstet. Gynecol. 121:829–846
2. Darragh TM, Colgan TJ, Cox JT, et al (2012) The lower anogenital squamous terminology standardization project for hpv-associated lesions: Background and consensus recommendations from the college of american pathologists and the american society for colposcopy and cervical pathology. J Low Genit Tract Dis 16:205–242.
3. López-Alarcón C, Arenas A, Lissi E, Silva E (2014) The role of protein-derived free radicals as intermediaries of oxidative processes. Biomol Concepts 5:119–130.
4. Luxford C, Dean RT, Davies MJ (2002) Induction of DNA damage by oxidised amino acids and proteins. Biogerontology 3:95–102.
5. Prabhu A, Sarcar B, Kahali S, et al (2014) Cysteine catabolism: a novel metabolic pathway contributing to glioblastoma growth. Cancer Res 74:787–796.
6. Slater TF, Bajardi F, Benedetto C, et al (1985) Protein thiols in normal and neoplastic human uterine cervix. FEBS Lett 187:267–271.
7. Erel O, Neselioglu S (2014) A novel and automated assay for thiol/disulphide homeostasis. Clin Biochem 47:326–332.
8. Nkabyo YS, Ziegler TR, Gu LH, et al (2002) Glutathione and thioredoxin redox during differentiation in human colon epithelial (Caco-2) cells. Am J Physiol Gastrointest Liver Physiol 283:G1352-1359.
9. Dirican N, Dirican A, Sen O, et al (2016) Thiol/disulfide homeostasis: A prognostic biomarker for patients with advanced non-small cell lung cancer? Redox Rep 21:197–203.
10. Eryilmaz M, Kozanhan B, Solak I, et al (2019) Thiol-disulfide homeostasis in breast cancer patients. J Cancer Res Ther 15:1062–1066.
11. Sezgin B, Pirinççi F, Camuzcuoğlu A, et al (2020) Assessment of thiol disulfide balance in early‐stage endometrial cancer. J Obstet Gynaecol Res 46:1140-1147.
12. Sezgin B, Kinci MF, Pirinççi F, et al (2020) Thiol-disulfide status of patients with cervical cancer. J Obstet Gynaecol Res 46:2423-2429.
13. Carneiro SR, da Silva Lima AA, de Fátima Silva Santos G, et al (2019) Relationship between Oxidative Stress and Physical Activity in Women with Squamous Intraepithelial Lesions in a Cervical Cancer Control Program in the Brazilian Amazon. Oxid Med Cell Longev 2019:8909852.
14. Bar–Or D, Lau E, Winkler J V (2000) A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia—a preliminary report. J Emerg Med 19:311–315.
15. Gonçalves TL, Erthal F, Corte CLD, et al (2005) Involvement of oxidative stress in the pre-malignant and malignant states of cervical cancer in women. Clin Biochem 38:1071–1075.
16. Goodman MT, McDuffie K, Hernandez B, et al (2000) Case-control study of plasma folate, homocysteine, vitamin B(12), and cysteine as markers of cervical dysplasia. Cancer 89:376–382.
17. Kwaśniewska A, Tukendorf A, Semczuk M (1995) [Frequency of HPV infection and level of glutathione in serum of women with cervix dysplasia]. Med Dosw Mikrobiol 47:213–218
18. Borges BES, Brito EB de, Fuzii HT, et al (2018) Human papillomavirus infection and cervical cancer precursor lesions in women living by Amazon rivers: investigation of relations with markers of oxidative stress. Einstein (Sao Paulo) 16:eAO4190.
19. Nöhammer G, Bajardi F, Benedetto C, et al (1986) Quantitative cytospectrophotometric studies on protein thiols and reactive protein disulphides in samples of normal human uterine cervix and on samples obtained from patients with dysplasia or carcinoma-in-situ. Br J Cancer 53:217–222.
20. Cruz-Gregorio A, Manzo-Merino J, Gonzaléz-García MC, et al (2018) Human Papillomavirus Types 16 and 18 Early-expressed Proteins Differentially Modulate the Cellular Redox State and DNA Damage. Int J Biol Sci 14:21–35.
21. Cadenas E (1997) Basic mechanisms of antioxidant activity. BioFactors 6:391–7
22. Dröge W (2003) Oxidative Stress and Aging. Adv Exp Med Biol 543:191-200.
23. Foppoli C, De Marco F, Cini C, Perluigi M (2015) Redox control of viral carcinogenesis: The human papillomavirus paradigm. Biochim Biophys Acta 1850:1622–1632.
24. Visalli G, Riso R, Facciolà A, et al (2016) Higher levels of oxidative DNA damage in cervical cells are correlated with the grade of dysplasia and HPV infection. J Med Virol 88:336–344.
25. Plugis NM, Weng N, Zhao Q, et al (2018) Interleukin 4 is inactivated via selective disulfide-bond reduction by extracellular thioredoxin. Proc Natl Acad Sci U S A 115:8781–8786.
26. Stegmann M, Barclay AN, Metcalfe C (2018) Reduction of leucocyte cell surface disulfide bonds during immune activation is dynamic as revealed by a quantitative proteomics workflow (SH-IQ). Open Biol 8:180079.
27. Hjortshøj S, Kristensen SR, Ravkilde J (2010) Diagnostic value of ischemia-modified albumin in patients with suspected acute coronary syndrome. Am J Emerg Med 28:170–176.
28. Gaze DC, Crompton L, Collinson P (2006) Ischemia-modified albumin concentrations should be interpreted with caution in patients with low serum albumin concentrations. Med Princ Pract 15:322–324.
29. Otrock ZK, Hatoum HA, Awada AH, et al (2009) Hypoxia-inducible factor in cancer angiogenesis: structure, regulation and clinical perspectives. Crit Rev Oncol Hematol 70:93–102.
30. Batmaz G, Kιlιç E, Özcan P, et al (2017) The role of oxidative stress in premalignant lesions. Eur J Gynaecol Oncol 38:282–285